1. Cancer versus heart failure patient self-declared potential interest in clinical trials

   • Maurie Markman
   • Larie Smoyer
   • Robert Montgomery

   Editor’s Commentary Pages: 1 - 5

2. The use of HER2 modulation in the adjuvant setting

   • Peter H. Johnson
   • Francisco J. Esteva

   OriginalPaper Pages: 9 - 16

3. Management of breast cancer in pregnancy

   • Richard Theriault
   • Karin Hahn

   OriginalPaper Pages: 17 - 21

4. Taxanes in breast cancer: An update

   • Alison K. Conlin
   • Andrew D. Seidman

   OriginalPaper Pages: 22 - 30

5. Diet and breast cancer

   • Eleni Linos
   • Michelle D. Holmes
   • Walter C. Willett

   OriginalPaper Pages: 31 - 41

6. Impact on quality of life of adjuvant therapy for breast cancer

   • Halle C. F. Moore

   OriginalPaper Pages: 42 - 46

7. Designing clinical trials for brain tumors: The next generation

   • Mark R. Gilbert

   OriginalPaper Pages: 49 - 54

8. Statistical issues in clinical trial design

   • Kenneth R. Hess

   OriginalPaper Pages: 55 - 59

9. Net clinical benefit: Functional endpoints in brain tumor clinical trials

   • Terri S. Armstrong
   • Mark R. Gilbert

   OriginalPaper Pages: 60 - 65

10. Therapeutic advances for glioblastoma multiforme: Current status and future prospects

    • H. Ian Robins
    • Susan Chang
    • Minesh Mehta

    OriginalPaper Pages: 66 - 70

11. Impact of molecular profiling on clinical trial design for glioblastoma

    • Arnab Chakravarti
    • Erin Tyndall
    • Jay Loeffler

    OriginalPaper Pages: 71 - 79